Two Sigma Investments, LP Cerevel Therapeutics Holdings, Inc. Transaction History
Two Sigma Investments, LP
- $40.3 Billion
- Q1 2024
A detailed history of Two Sigma Investments, LP transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 19,700 shares of CERE stock, worth $812,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,700
Previous 19,700
-0.0%
Holding current value
$812,230
Previous $835,000
0.36%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CERE
# of Institutions
227Shares Held
150MCall Options Held
939KPut Options Held
961K-
Bain Capital Investors LLC Boston, MA65.7MShares$2.71 Billion61.94% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$445 Million9.58% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.56MShares$312 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.46MShares$308 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$225 Million0.01% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Market Cap $6.42B
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...